Chemical Structure : TPST-1120
货号: PC-24111Not For Human Use, Lab Use Only.
Amezalpat (TPST-1120, TPST1120) is potent, selective and orally bioavailable inhibitor of peroxisome proliferator-activated receptor α (PPARα) with IC50 of 0.04 uM (human PPARα), >250-fold selectivity over the other PPAR isoforms (PPAR β/δ and γ).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Amezalpat (TPST-1120, TPST1120) is potent, selective and orally bioavailable inhibitor of peroxisome proliferator-activated receptor α (PPARα) with IC50 of 0.04 uM (human PPARα), >250-fold selectivity over the other PPAR isoforms (PPAR β/δ and γ).
TPST-1120 exhibits potent anti-tumor immune responses and significant tumor regression in syngeneic models of breast, lung, colon, pancreatic and melanoma in addition to xenograft models of CLL, AML, pancreatic and melanoma cancers as a monotherapy or in combination with chemotherapy.
Combination of TPST-1120 plus anti-PD-1 therapy resulted in synergistic tumor reduction and durable antitumor immunity in multiple syngeneic mouse models.
分子量 | 555.72 | |
分子式 | C34H41N3O4 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Patent WO2014099503 A1.
2. Chan C. Whiting, et al. Cancer Res (2019) 79 (13_Supplement): 3606.
3. Mark Yarchoan, et al. Cancer Res Commun. 2024 Apr 18;4(4):1100-1110.
4. US Patent No.676,754 B2. Triazolone compounds and uses thereof; 2017.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright